Prevention of bone loss by estradiol valerate combined with medroxyprogesterone acetate among postmenopausal women with osteopenia

Zhonghua yi xue za zhi

Volumn 82, Issue 23, 2002, Pages 1593-1598

  Lu, Junli ^a   Lin, Shouqing ^a   Zhang, Lisong ^a   Yu, Wei ^a   Shen, Ying ^a   Zhang, Ying ^a   Chen, Fengling ^a  

^a PEKING UNION MEDICAL COLLEGE HOSPITAL   (China)

Author keywords

[No Author keywords available]

Indexed keywords

DRUG DERIVATIVE; ESTRADIOL; ESTRADIOL VALERATE; MEDROXYPROGESTERONE ACETATE; PROGESTERONE DERIVATIVE;

ADULT; ARTICLE; BONE DENSITY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG COMBINATION; FEMALE; HUMAN; METABOLIC BONE DISEASE; MIDDLE AGED; PHYSIOLOGY; POSTMENOPAUSE OSTEOPOROSIS; RANDOMIZED CONTROLLED TRIAL;

ADULT; BONE DENSITY; BONE DISEASES, METABOLIC; DRUG THERAPY, COMBINATION; ESTRADIOL; FEMALE; HUMANS; MEDROXYPROGESTERONE 17-ACETATE; MIDDLE AGED; OSTEOPOROSIS, POSTMENOPAUSAL; PROGESTERONE CONGENERS;

EID: 0042128803     PISSN: 03762491     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (0)